Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Ziv-aflibercept in Ocular Disease Short and Long-term Study

NCT02486484 is registered in ClinicalTrials.gov with Rafic Hariri University Hospital as lead sponsor.

NCT NCT02486484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02486484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Ziv-aflibercept in Ocular Disease Short and Long-term Study
Lead sponsor
Rafic Hariri University Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2015
Completion date
December 31, 2019
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

choroidal neovascularization, cystoid macular edema, diabetic retinopathy, macular degeneration, neovascularization, recurrent pterygium, retinal neovascularization, retinal vein occlusion